Endometrial Carcinoma (INTRO)

download Endometrial Carcinoma (INTRO)

of 35

Transcript of Endometrial Carcinoma (INTRO)

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    1/35

    ENDOMETRIAL

    CARCINOMA

    ByA.CharumathyFinal yr mbbs

    ll unit KGHMadras medical college

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    2/35

    EPIDEMIOLOGY

    In India, incidence is 5-7%.Cervical cancerremains the most common gynecologicalmalignancy.

    4THleading cancer in incidence but only 8thleading cause o death rom malignancy among!omen.

    "ore re#uently occuring gynecologicalcancer$&-5%' in develo(ed countries.

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    3/35

    7 times more common in )orth *mericansthan Chinese counter(arts.

    "ostly occurs in +th7thdecade o lie.

    &-5% - (erimeno(ausal !omen

    5% - belo! 45yrs o age

    verall 5 year survival rate is

    75% - *denocarcinoma

    5&% - clear cell serous C*"ostly s(oradic,&% is hereditary.

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    4/35

    /I01 2*CT/0)ulli(arity

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    5/35

    Tamo3ien

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    6/35

    FACTORS REDUCINGRISK

    ral Contrace(tive ills-4&-5&%rogesterone-%arly meno(ause

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    7/35

    PATHOLOGY

    )/"*6)"T/I"

    PROLIFERATIVEPHASE

    SECRETORY PHASE

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    8/35

    ENDOMETRIAL

    HYPERPLASIAIt is an increased (rolieration o theendometrial glands relative to the stroma,resulting in an increased gland-to-stroma

    ratio !hen com(ared !ith normal(rolierative endometrium.

    volves in the bac9ground o (rolierativeendometrium due to (rotracted oestrogenstimulation in the absence o (rogestin.

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    9/35

    C6*00I2IC*TI)

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    10/35

    GROSS MORPHOLOGY

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    11/35

    HISTOPATHOLOGY

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    12/35

    ATYPICAL HYPERPLASIA

    *ty(ical eatures-:

    6arge nuclei o variable si;e sha(e

    6oss o (olarityIncrease in nuclear to cyto(lasmic ratio

    rominent nucleoli

    Irregularly clum(ed chromatin !ith

    (arachromatin clearing

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    13/35

    The endometrial glands are highly irregular in size and shaeand sho! "re#uent outou$hings. The atypia is characterized

    by enlarged round nu$lei% irregular $hromatin distri&ution% androminent nu$leoli.

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    14/35

    ENDOMETRIAL

    CARCINOMAndometrial cancer is a biologically andhistologically diverse grou( o neo(lasmscharacteri;ed by a dualistic model o

    (athogenesis.Ty(e I endometrioid adenocarcinomascom(rise 75 (ercent o all cases. They areestrogen deendent% lo! grade% and

    deri'ed "rom atyi$al endometrialhyerlasia(

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    15/35

    In contrast, ty(e II cancers usually haveserous or $lear $ell histology% nore$ursor lesion% and a more aggressiveclinical course

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    16/35

    Feature Tye I Tye II

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    17/35

    CLASSIFICATION

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    18/35

    ADENOCARCINOMA

    *lso called lands resembling normal endometrialglands,

    Columnar cells !ith basally oriented nuclei ,

    6ittle or no intracyto(lasmic mucin

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    19/35

    2eatures o carninoma ?

    esmo(lastic reaction@ac9 to bac9 glands !ithout intervening

    stroma

    3tensive (a(illary (attern

    0#uamous e(ithelial dierentiation

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    20/35

    GROSS MORPHOLOGY

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    21/35

    HISTOPATHOLOGY

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    22/35

    GRADING (FIGO)

    @ased on di""erentiation%glandularar$hite$ture and nu$lear "eaturestumours are graded into ollo!ing

    >/* I - A 5% 06I >/BTH>/* II - +-5&% 06I>/BTH

    >/* III - 5&% 06I >/BTH

    PRESENCE OF NUCLEAR ATYPIAINCREASES GRAE !Y " IRRESPECTI#E OFARC$ITECTURAL GRAING.%

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    23/35

    >/* II >/* III

    >/* I

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    24/35

    VARIANTS

    Bith areas o s#uamous dierentiation@enign -*denocanthoma

    "alignant -*denos#uamous

    CarcinomaDilloglandular dierentiation

    -Bell dierentiated

    -Tumour cells arranged alongibrovascular stal9s

    0ecretory carcinoma

    -/are variant,e3cellent (rognosis

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    25/35

    SECRETORY CARCINOMA

    The &e'p(astic )(a&ds c'&tai& (ar)e su&nu$lear 'a$uoles i*parti&) a+iano )ey* appeara&ce.

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    26/35

    MUCINOUS CARCINOMA

    5% o endometrial carcinoma.

    >ood (rognosis

    @ehaves as normal endometroid tumour

    E o tumour com(osed o cells !ithintracyto(lasmic mucin

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    27/35

    Ab,&da&t mu$inis -i((i&) the cyt'p(as* '- neolasti$ $ells(a(s' prese&t i&(,*i&a( spaces

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    28/35

    SEROUS CARCINOMA

    F-4% o endometrial carcinoma

    *ggressive tumour !ith (oor (rognosis

    0imilar to serous carcinoma o ovary

    allo(ian tube*lso called

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    29/35

    Psammoma &odies are seen.

    High rate o reccurence.

    0erous carcinoma have lymho'as$ular

    and dee myometrial in'asion(

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    30/35

    The i*a)e sh'saillary $lusters'- high,grade neolasti$ $ells.N,*er',s mitoti$ "iguresca& be see&. Other -eat,res that are -re/,e&t(y see&

    i&c(,de ne$rosis% sammoma &odies0 a&d in'asion o" the myometrium.

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    31/35

    CLEAR CELL

    CARCINOMAA5% o endometrial carcinoma

    ccurs in older !omen.

    *ggressive tumour !ith (oor (rognosis.

    "i3ed histologic (attern$aillary%tu&ulo$y$ti$% glandular -solid tyes.(

    Cells have hobnail coniguration arranged in(a(illae !ith hyanili;ed stal9

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    32/35

    The t,*'r is c'*p'sed '-olygonal $ellsith a&undant $lear$ytolasm1d,e t' )(yc')e& c'&te&t2. It has distin$t $ytolasmi$

    &ordersa&d *'derate cyt'(')ic atypia.

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    33/35

    SQUAMOUS CARCINOMA

    /are variant, es(ecially the (urevariety.ten glands are (resent.

    ten associated !ith cervical stenosis,chronic inlammation, (yometra at the time odiagnosis

    It has a very (oor (rognosis !ith F+%survival rate.

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    34/35

    SPREAD

    Contiguous s(read to endometrium

    "yometrium invasion

    ee(er invasion o lym(hatic vascular

    s(aceirect s(read to (ara aortic nodes.

    Cervical involvement

    "etastasis

  • 7/24/2019 Endometrial Carcinoma (INTRO)

    35/35